Considering that the HDAC inhibition effect of VPA is linked to stroke outcomes through the modulation of inflammation, the decreases in inflammatory markers associated with VPA use in our study may support the anti-inflammatory effects of VPA and suggest that HDACs act as mediators of this process. Here, HDAC9 is linked to stroke disorder.